To avoid graft‐versus‐host response, CD45+ hematopoietic cells were depleted before injecting equal numbers of EpCAM+ (epithelial cell surface marker) breast cancer cells into the fourth mammary fat pads (Fig 8A). Here, PTPRC is linked to breast cancer.